Celgene Commitment Campaign Envisions A Future Where Lymphoma is a Distant Memory

This year’s ASH meeting will feature nearly 70 studies that include the investigational use of Celgene agents in lymphoma and leukemia.

At ASH this year, Celgene has unveiled a new campaign that underscores its ongoing commitment to lymphoma research. Celgene has multiple ongoing phase III programs across a number of aggressive and indolent diseases.

The campaign slogan speaks to “making lymphoma a distant memory” and features a dinosaur skeleton whose bones spell out the word “lymphoma”. This reflects the commitment Celgene researchers have, now and in the future, to develop treatments and advance care in lymphoma. Their vision is for a future in which lymphoma is more than treatable, it’s a distant memory.

This year’s ASH meeting will feature nearly 70 studies that include the investigational use of Celgene agents in lymphoma and leukemia – further exemplifying Celgene’s commitment to lymphoma research.

To learn more about Celgene and its lymphoma programs – visit http://www.researchoncology.com/areas-of-research/lymphoma/science/